Who owns ACURX PHARMACEUTICALS INC COM NEW?
- Ticker: ACXP
- CUSIP Number: 00510m203
Tip: Access positions for across all investors
Analyze quarterly positions in Acurx Pharmaceuticals with up to 7 years of data, all consolidated into one spreadsheet
Download as csvTop investors of Acurx Pharmaceuticals stock
Who bought or sold ACURX PHARMACEUTICALS INC COM NEW this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Vanguard Group | 23k | $58k | 100% | Dec 2025 |
|
| Prospect Financial Services | 20k | $49k | 0% | Dec 2025 |
|
| Northern Trust | 17k | $42k | 100% | Dec 2025 |
|
| Geode Capital Management | 12k | $31k | 100% | Dec 2025 |
|
| Jane Street | 11k | $27k | 100% | Dec 2025 |
|
| Tower Research Capital | 2.9k | $7.2k | 168% | Dec 2025 |
|
| Wells Fargo & Company | 2.3k | $5.7k | 100% | Dec 2025 |
|
| Nbc Securities | 1.5k | $3.7k | 0% | Dec 2025 |
|
| Group One Trading | 283.00 | $705.009600 | -5% | Dec 2025 |
|
| UBS Group | 169.00 | $338.000000 | 100% | Dec 2025 |
|
| Cornerstone Planning Group | 167.00 | $432.997600 | 149% | Dec 2025 |
|
| Advisor Group Holdings | 100.00 | $249.000000 | -59% | Dec 2025 |
|
| BlackRock | 60.00 | $148.998000 | 0% | Dec 2025 |
|
| SBI Securities | 13.00 | $31.999500 | 0% | Dec 2025 |
|
Who sold out of Acurx Pharmaceuticals?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Susquehanna International | Sep 2025 | 17k | $72k |
| Sabby Management | Sep 2025 | 8.7k | $37k |
| GPS Wealth Strategies Group | Sep 2025 | 1.2k | $5.3k |
| Advisory Services Network | Sep 2025 | 59.00 | $252.997900 |
| Sontag Advisory | Sep 2025 | 15.00 | $64.999500 |